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Introduction
The use of hypercapnic gas to provoke anxiety or panic responses, 
in both patient and healthy volunteers, has a long history in psy-
chiatric research. Various concentrations of CO2 (ranging from 
4% to 65%) and durations of inhalation (from five seconds to 20 
minutes) are used to evoke different anxiety effects. High doses 
(20–35%) administered in a single breath produce acute arousal 
similar to symptoms of panic disorder, while lower doses (4–9%) 
inhaled for longer produce gradual and sustained arousal (Forsyth 
and Eifert, 1998). Many studies use the 7.5% carbon dioxide 
(CO2) challenge to induce an acute anxiety response experimen-
tally, which produces symptoms similar to those associated with 
Generalised Anxiety Disorder (Bailey et al., 2005). This has been 
shown to increase subjective and physiological indices of state 
anxiety reliably (Bailey et al., 2005). The 7.5% CO2 challenge 
model has been used extensively to test novel anxiolytic com-
pounds for potential efficacy (Bailey et al., 2007), and to explore 
the effects of anxiety on cognitive processes (Attwood et al., 
2013; Cooper et al., 2011, 2013; Garner et al., 2012).
The 7.5% CO2 challenge model can be used in both healthy 
volunteers and participants from clinical samples. Here, we focus 
on studies recruiting healthy volunteers. Although some of these 
studies specify upper and lower thresholds for anxiety sensitivity 
and/or trait anxiety, exclusion criteria typically focus only on cur-
rent and past psychiatric history, rather than subclinical variation 
in trait anxiety. Therefore, some participants recruited into these 
studies will have high levels of anxiety sensitivity or trait anxiety. 
Previous studies have suggested that some individuals vary in 
their sensitivity and response to the 7.5% CO2 challenge (Bailey 
et al., 2005). It is possible that anxiety sensitivity or trait anxiety, 
hereafter referred to as ‘anxiety proneness’, may account for 
some of this interindividual variability in response. Evidence 
from previous psychosocial and biological challenge studies sug-
gests that anxiety proneness may be associated with heightened 
subjective response. High trait anxiety is associated with greater 
state anxiety and negative affect during the Trier Social Stress 
Test, a psychosocial stress induction procedure (Villada et al., 
2014). Additionally, high trait anxiety and anxiety sensitivity are 
associated with subjective response during voluntary hyperventi-
lation studies, despite similar levels of autonomic arousal 
(Whittal and Goetsch, 1995; Whittal et al., 1994). Anxiety sensi-
tivity is also associated with response to inhalations of 5.5% and 
20% CO2 (Rapee et al., 1992), and response to repeated inhala-
tion of 35% CO2 (Beck et al., 1996). As different concentrations 
of CO2 produce varying degrees of anxious response, caution 
should be exercised when comparing results across CO2 chal-
lenge studies (Zvolensky and Eifert, 2001).
In the current study, we examined data from a series of 7.5% 
CO2 challenge studies in order to determine whether there is an 
association between anxiety proneness and a range of subjective 
and physiological responses. While other studies have examined 
the relationship between anxiety proneness and response to CO2 
challenge (Beck et al., 1996; Forsyth et al., 1999; Rapee et al., 
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1992; Zinbarg et al., 2001; Zvolensky et al., 2001), to the best of 
our knowledge, this is the first study to examine specifically 
whether there is a differential association between these meas-
ures and response to both 7.5% CO2 and placebo (medical air) 
inhalation. We predicted that anxiety proneness would be associ-
ated with a stronger response in both conditions, and we were 
also interested in whether the magnitude of this response differed 
between the two conditions, and whether these relationships were 
stronger for measures of anxiety sensitivity or trait anxiety.
Methods
Study inclusion and design
Data from 418 participants (aged 18–55 years) were collated from 
15 experiments (including seven experiments reported in six pub-
lished studies (Attwood et al., 2014; Cooper et al., 2011, 2013; 
Garner et al., 2011, 2012; Mattys et al., 2013) that used the 7.5% 
CO2 inhalation model as a method of acutely inducing anxiety. All 
studies were conducted by the Tobacco and Alcohol Research 
Group at the University of Bristol across seven years (2007–
2014), and used a repeated-measures design, with inhalation of 
7.5% CO2-enriched air or medical air as the within-subjects fac-
tor. Inhalation order was counterbalanced across participants, and 
gases were administered single blind.
Participants
All participants were in good physical and psychiatric health, 
determined by self-report and completion of a medical checklist 
and a neuropsychiatric interview (adapted from the Mini 
International Neuropsychiatric Interview). Exclusion criteria for 
all studies included current or lifetime history of psychiatric dis-
order, drug dependence (except caffeine), asthma/respiratory ill-
ness, cardiovascular disease, migraines, recent (within eight 
weeks) use of prescribed drugs (all via self-report). Participants 
were required to have a body mass index between 18 and 30 kg/m2, 
systolic and diastolic blood pressure <140 and 90 mmHg, respec-
tively, and heart rate between 50 and 90 beats per minute (bpm). 
Participants were excluded if they were pregnant or had recently 
used recreational drugs (verified by urine screen). All studies 
were approved by the Faculty of Science Research Ethics 
Committee at the University of Bristol, and received monetary 
reimbursement ranging from £20 to £22.
Gas mixture
The gas mixtures used were CO2 7.5%/O2 21%/N 71.5% and 
medical air (O2 21%). The gas was delivered to participants 
through an oronasal facemask (Hans Rudolph, Inc., Shawnee, 
KS), which was attached to a 500 L Douglas bag (Cranlea Human 
Performance Testing Ltd., Birmingham, UK) with tubing.
Screening
All participants first completed an initial telephone screen to 
determine eligibility before attending testing. On the test day, 
participants provided signed informed consent before completing 
further screening procedures, including breath and urine testing 
and an assessment of blood pressure, heart rate, height and 
weight, and completion of a neuropsychiatric interview.
Procedure
All studies were comprised of one test session, during which par-
ticipants completed two inhalations of up to 20 minutes duration. 
One inhalation was of 7.5% CO2-enriched air, and the other was 
medical air (placebo). The 7.5% CO2 and medical air inhalations 
were counterbalanced across participants.
All participants completed the Spielberger State–Trait 
Anxiety Inventory state (STAI-S) and trait (STAI-T) sub-scales 
(Spielberger et al., 1983), the Anxiety Sensitivity Inventory 
(ASI) (Reiss et al., 1986), and the Positive and Negative Affect 
Schedule positive (PANAS-P) and negative (PANAS-N) affect 
sub-scales (Watson et al., 1988).
The STAI-T (measuring trait anxiety) and ASI (measuring 
anxiety sensitivity) were completed at baseline, and measures of 
subjective (STAI-S and PANAS) and physiological (blood pres-
sure and pulse) response were completed at baseline and imme-
diately after each inhalation.
Statistical analysis
For each participant, STAI-S, PANAS-P, PANAS-N, systolic blood 
pressure (SBP) and heart rate were analysed at baseline, post-CO2 
and post-air. Diastolic blood pressure (DBP) was not analysed, as 
previous studies have indicated a minimal effect of 7.5% CO2 inha-
lation on DBP. Linear regression was used, with STAI-T and ASI as 
the independent predictor variables against, each of the outcome 
measures in each gas condition (CO2/air). We adjusted our analyses 
for study and sex, and then mutually adjusted for STAI-T or ASI in 
the regression analyses, and tested for differences in regression 
slopes between the two outcomes in the unadjusted and adjusted 
analyses. The assumption of linearity was met for all variables, and 
independence of observations was assessed by the Durbin–Watson 
statistic, which indicated that there was no correlation between the 
residuals of any of the variables. All variables met the assumption 
of homogeneity of variance, which was assessed by plotting the 
residuals over the standardized predicted values, and had normally 
distributed residuals, as assessed through P-P plots.
We also conducted a number of secondary analyses. First, to 
take into account baseline anticipatory anxiety, we re-ran our 
analyses using the difference between measures taken post-CO2 
and post-air inhalation (e.g., STAI-S post-CO2 minus STAI-S 
post-air) as the outcomes. Second, the three sub-scales of anxiety 
sensitivity (physical, cognitive and social concerns), as defined 
by Zinbarg et al. (1997), were independently regressed against 
each outcome to determine any of these sub-scales was more 
strongly associated with outcome. Third, to assess whether there 
is a stronger coupling between autonomic arousal and subjective 
response in individuals with high trait anxiety or anxiety sensitiv-
ity, we performed a median split of anxiety sensitivity and trait 
anxiety and investigated the correlation between subjective anxi-
ety (STAI-S) and autonomic response (heart rate) in high and low 
groups separately.
Analyses were conducted using SPSS v21.0. The data that 
form the basis of the results presented here are available on the 
University of Bristol Research Data Repository (DOI: 10.5523/
bris.motn077rd66s15i0gkg6i9pi7).
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Results
Participant demographics
Participants (n=418; 50% female) were aged between 18 and 52 
years (M=22.6, SD=4.8), and had STAI-T scores between 20 and 
70 (M=34.5, SD=8.2) and ASI scores between 0 and 47 (M=17.0, 
SD=10.0). At baseline, STAI-S scores were between 20 and 63 
(M=31.6, SD=8.1), PANAS-P scores were between 14 and 47 
(M=29.9, SD=6.1) and PANAS-N scores were between 9 and 
31 (M=11.4, SD=2.4). SBP values were between 75 and 160 
mmHg (M=111.7, SD=13.6), and heart rates were between 31 and 
107 bpm (M=69.0, SD=10.7). Correlations between baseline meas-
ures are shown in Table 1. Due to missing data, the total sample avail-
able for analysis in the primary analyses ranged from 396 to 415.
Trait anxiety
Trait anxiety (STAI-T) was positively associated with higher 
state anxiety during CO2 inhalation (B 0.23, 95% CI 0.10 to 0.37, 
p=0.001) and air inhalation (B 0.45, 95% CI 0.35 to 0.54, 
p<0.001). These estimates differed from each other (pdiff=0.010). 
Higher trait anxiety was negatively associated with positive 
affect (PANAS-P) during CO2 inhalation (B –0.21, 95% CI −0.29 
to −0.12, p<0.001) and air inhalation (B −0.30, 95% CI −0.30 to 
−0.22, p<0.001), and there was weak evidence that these esti-
mates differed from each other (pdiff=0.060). Additionally, higher 
trait anxiety was associated with higher negative affect 
(PANAS-N) during CO2 inhalation (B 0.13, 95% CI 0.06 to 0.20, 
p=0.001) and air inhalation (B 0.11, 95% CI 0.07 to 0.16, 
p<0.001), with no evidence that these estimates differed 
(pdiff=0.712). Trait anxiety was negatively associated with SBP 
after CO2 inhalation (B –0.24, 95% CI −0.42 to –0.07, p=0.008) 
and air inhalation (B −0.18, 95% CI −0.34 to −0.20, p=0.028), 
with no evidence that these estimates differed (pdiff=0.335). 
Finally, high trait anxiety was positively associated with heart 
rate after CO2 inhalation (B −0.17, 95% CI −0.35 to 0.00, 
p=0.050) but not after air inhalation (B −0.07, 95% CI −0.20 to 
0.05, p=0.256), with no evidence that these estimates differed 
(pdiff=0.177). These results are shown in Table 2, and were not 
altered substantially by adjustment for ASI.
Anxiety sensitivity
Anxiety sensitivity (ASI) was not associated with state anxiety 
during CO2 inhalation (B 0.05, 95% CI −0.06 to 0.16, p=0.392), 
but was associated with higher state anxiety during air inhalation 
(B 0.25, 95% CI 0.17 to 0.34, p<0.001), and these estimates dif-
fered (pdiff=0.002). Anxiety sensitivity was negatively associated 
with positive affect during air inhalation (B −0.07, 95% CI −0.14 
to 0.00, p=0.038), but not during CO2 inhalation (B –0.02, 95% 
CI −0.09 to 0.05, p=0.543), with no evidence that these estimates 
differed (pdiff=0.162). Higher anxiety sensitivity was associated 
with higher negative affect during both CO2 inhalation (B 0.12, 
95% CI 0.06 to 0.17, p<0.001) and air inhalation (B 0.14, 95% CI 
0.10 to 0.18, p<0.001), with no evidence that these estimates dif-
fered (pdiff=0.449). Finally, anxiety sensitivity was not associated 
with any cardiovascular outcomes (p>0.19). These results are 
shown in Table 2, and were not altered substantially by adjust-
ment for study, sex or STAI-T.
Secondary analyses
The pattern of results for the analysis of change scores was essen-
tially the same as in our primary analyses (see Supplementary 
Table 1). Similarly, the analysis of ASI sub-scales did not reveal 
any clear difference in the pattern of results across the three sub-
scales (see Supplementary Table 2).
There was no association of state anxiety with heart rate 
among low ASI individuals during CO2 inhalation (r=+0.11, 
n=218, p=0.101) or air inhalation (r=−0.04, n=219, p=0.563). 
There was a positive association of state anxiety with heart rate 
among high ASI individuals during CO2 inhalation (r=+0.25, 
n=197, p=0.001), but not during air inhalation (r=+0.08, n=195, 
p=0.273). However, there was only weak evidence that these esti-
mates differed from each other (p=0.085).
In contrast, there was a positive association of state anxiety and 
heart rate among low STAI-T individuals (r=+0.19, n=166, p=0.015) 
during CO2 inhalation but not during air inhalation (r=+0.06, n=169, 
p=0.063), but no clear evidence that these estimates differed from 
each other (p=0.230). There was a positive association of state anxi-
ety and heart rate among high STAI-T individuals during CO2 inha-
lation (r=+0.14, n=219, p=0.037), and no association during the air 
inhalation (r=+0.03, n=220, p=0.697), but no clear evidence that 
these estimates differed from each other (p=0.250).
Discussion
Our data indicate that anxiety proneness is associated with 
response to 7.5% CO2 challenge. Moreover, while these associa-
tions are observed for response under both 7.5% CO2 and air 
Table 1. Correlation coefficients (Pearson’s r) for baseline measures.
STAI-T ASI STAI-S PANAS-P PANAS-N SBP Heart rate
STAI-T +0.329 +0.634 – 0.228 +0.296 −0.173 −0.016
ASI +0.329 +0.384 – 0.006 +0.289 −0.008 −0.038
STAI-S +0.634 +0.384 – 0.312 +0.433 −0.105 +0.001
PANAS-P −0.228 −0.006 −0.312 −0.023 +0.100 −0.121
PANAS-N +0.296 +0.289 +0.433 – 0.023 −0.035 −0.082
SBP −0.173 −0.008 −0.105 + 0.100 −0.035 +0.019
Heart rate −0.016 −0.038 +0.001 −0.121 −0.082 +0.019  
STAI-S, State–Trait Anxiety Inventory state sub-scale; STAI-T, State–Trait Anxiety Inventory trait sub-scale; ASI, Anxiety Sensitivity Index; PANAS-P, Positive and  
Negative Affect Schedule positive affect sub-scale; PANAS-N, Positive and Negative Affect Schedule negative affect sub-scale; SBP, systolic blood pressure.
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conditions, the strength of the association is stronger in the air 
condition for subjective measures (in particular state anxiety as 
measured by the STAI-S). This suggests that the inhalation of 
7.5% CO2-enriched air may have similar effects across all partici-
pants, inducing subjective and physiological responses in both 
anxiety sensitive and low and high trait anxiety individuals, 
whereas the anticipatory anxiety associated with the procedure is 
greater in anxiety sensitive and high trait individuals (leading to 
a relatively stronger response in the air condition). It is notable 
that this pattern of results was observed for subjective effects, but 
not physiological effects. Interestingly, these results were robust 
to mutual adjustment, suggesting that anxiety proneness may (in 
part) be independently associated with subjective responding 
during air inhalation. Additionally, the pattern of results remained 
largely similar across ASI sub-scales. There was no evidence for 
coupling of subjective and autonomic arousal in low or high trait 
individuals during either inhalation condition, and only weak evi-
dence of coupling in high anxiety sensitive individuals during 
CO2 inhalations.
There are some limitations to the current study that should be 
considered when interpreting these results. First, participants 
were generally recruited from staff and students at the University 
of Bristol. They are therefore relatively unrepresentative of the 
general population (e.g. they tended to be relatively young). 
Second, all of the studies included in this analysis were con-
ducted in the same laboratory and used the same general inclu-
sion and exclusion criteria. Therefore, it is possible that some of 
the participants took part in more than one study. Unfortunately, 
due to the anonymous nature of the data, it is not possible to 
identify repeat participants. Third, we did not include a baseline 
measure of depression symptoms. Therefore, although depres-
sion symptoms may account for some variation in anxiety 
response, we were unable to explore this here. Finally, an older 
version of the Anxiety Sensitivity Index was employed in the 
studies used for this analysis. The original 16-item ASI contains 
eight items within the physical symptoms subgroup and four 
items within the cognitive and social symptoms subgroups, pos-
sibility limiting the reliability of the latter two (Taylor et al., 
2007). A more appropriate measure would have been the ASI-III, 
which has good validity across clinical and non-clinical samples 
in measuring lower order factors of physical, cognitive and social 
concerns.
These results have important implications for the design and 
conduct of future 7.5% CO2 challenge studies, which may need 
to take anxiety proneness into account, either when recruiting 
participants or in the resulting analyses. The greater subjective 
response in the air condition relative to the 7.5% CO2 condition 
means that it may be more difficult to demonstrate an effect of 
7.5% CO2 inhalation relative to air in anxiety-prone individuals. 
By extension, the impact of a pharmacological agent (such as a 
putative novel anxiolytic) may be more difficult to detect. This 
may mean that important effects are missed if, by chance, a sam-
ple with a substantial proportion of anxiety-prone participants is 
recruited.
It is worth noting that we only observed differential associa-
tions in response to 7.5% CO2 and air inhalations for subjective 
responses, and not objective responses. Unfortunately, we did not 
have sufficiently comparable data to investigate corresponding 
effects on cognitive task performance, and therefore cannot say 
whether anxiety proneness is associated with changes 
in performance on these tasks. However, one study explicitly 
investigating the link between trait anxiety and cognitive perfor-
mance during the 7.5% CO2 challenge found that trait anxiety was 
associated with increased alerting and orienting network function 
(Garner et al., 2012). These findings are consistent with other evi-
dence that individuals prioritise their attentional recourses towards 
monitoring and detecting threating stimuli when aroused (Fan 
et al., 2002). Given that many studies in healthy volunteers are 
conducted in order to investigate the effects of anxiety on cogni-
tive processes, this clearly requires further investigation.
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